Kelemen Jozsef, Sztermen Marton, Dakos Eva, Agocs Gergely, Budai Jozsef, Katona Jozsef, Szekeressy Zsuzsanna, Sipos Laszlo, Papp Zoltan, Bata Mate, Karczub Janos, Korompai Mate, Dunai Zsuzsanna A, Kocsis Bela, Szabo Dora, Eross Lorand
Deparment of Neurosurgery and Neurointervention, Semmelweis University, 1085 Budapest, Hungary.
Department of Biophysics and Radiation Biology, Semmelweis University, 1094 Budapest, Hungary.
Antibiotics (Basel). 2024 Nov 17;13(11):1093. doi: 10.3390/antibiotics13111093.
An external ventricular drain (EVD) is used to release elevated intracranial pressure by draining cerebrospinal fluid (CSF) from the brain's ventricles. The establishment of an EVD is one of the most commonly performed neurosurgical procedures to treat intracranial pressure in patients. Nevertheless, infections are very frequent complications. Identifying the risk factors for EVD-related infections is a key to improving patient safety and outcomes. We conducted a retrospective, single-center study of patients who underwent EVD implantation between January 2022 and March 2024. Patients were classified into infected and non-infected groups based on their clinical symptoms, as well as laboratory and microbiological results. Patient characteristics and possible risk factors for infection were compared between the two groups. In total, 123 patients treated with 156 EVDs were included in this study, with a mean age of 55.8 (range: 25-84) years. EVD-associated infections were observed in 37 patients (30%). We found no significant association between infection risk and patient characteristics, including gender, primary diagnosis, craniotomy, or immunosuppression. There was no significant difference in terms of EVD insertion, i.e., whether the insertion took place in the operating room (OR) with antibiotic prophylaxis or outside the OR with no periprocedural antibiotic treatment. However, within the intensive care unit (ICU), EVD infection was much lower (13%) if EVD insertion took place in a single-bed room compared to multiple-bed room insertions (34%). Furthermore, there were significant differences in terms of the duration of first EVD (both single and multiple catheterizations) ( < 0.0001) and the total catheterization time ( = 0.0001). Additionally, there was a significant association with patient days in the ICU and EVD catheterization. Revisiting infection control measures is necessary, with special attention to the replacement of EVDs in single-bed ICU rooms, to introduce antibiotic prophylaxis in the ICU. Minimizing unnecessary EVD manipulation during catheterization is crucial in order to decrease the risk of EVD infection.
外置脑室引流管(EVD)用于通过引流脑室中的脑脊液(CSF)来缓解颅内压升高。EVD置管是治疗患者颅内压最常用的神经外科手术之一。然而,感染是非常常见的并发症。识别与EVD相关感染的危险因素是提高患者安全性和改善预后的关键。我们对2022年1月至2024年3月期间接受EVD植入的患者进行了一项回顾性单中心研究。根据患者的临床症状以及实验室和微生物学结果,将患者分为感染组和非感染组。比较两组患者的特征和可能的感染危险因素。本研究共纳入123例接受156根EVD治疗的患者,平均年龄55.8岁(范围:25 - 84岁)。37例患者(30%)发生了EVD相关感染。我们发现感染风险与患者特征之间无显著关联,包括性别、初步诊断、开颅手术或免疫抑制。EVD置管方面无显著差异,即置管是在手术室(OR)进行并预防性使用抗生素,还是在OR外进行且围手术期未使用抗生素治疗。然而,在重症监护病房(ICU)内,如果EVD在单人病房置管,EVD感染率(13%)远低于在多人病房置管(34%)。此外,首次EVD置管时间(单根和多根导管置管)(<0.0001)和总导管置管时间(=0.0001)存在显著差异。此外,ICU住院天数与EVD置管存在显著关联。有必要重新审视感染控制措施,特别关注单人ICU病房中EVD的更换,在ICU引入抗生素预防措施。在置管过程中尽量减少不必要的EVD操作对于降低EVD感染风险至关重要。